(Q37725848)

22 August 2017

1 reference

title

Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients (English)

1 reference

Maria-Antonia Quera-Salva

22 August 2017

0 references

Christian Guilleminault

series ordinal

3

object named as

Christian Guilleminault

0 references

series ordinal

1

object named as

Maria-Antonia Quera-Salva

0 references

author name string

Patrick Lemoine

series ordinal

2

1 reference

22 August 2017

publication date

1 April 2010

1 reference

22 August 2017

number of pages

8

1 reference

inferred from page(s)

published in

Human Psychopharmacology

1 reference

22 August 2017

volume

25

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

222-229

1 reference

Sleep and psychiatric disorders. A meta-analysis

22 August 2017

cites work

1 reference

Delta sleep EEG in depressed adolescent females and healthy controls.

21 January 2018

1 reference

7 January 2021

Slow-wave activity in NREM sleep: sex and age effects in depressed outpatients and healthy controls

1 reference

7 January 2021

Mirtazapine: a review of its use in major depression and other psychiatric disorders

1 reference

7 January 2021

Microstructure of sleep in depressed patients according to the cyclic alternating pattern

1 reference

7 January 2021

Pharmacological approaches to the treatment of residual symptoms

1 reference

7 January 2021

A rating scale for depression

1 reference

7 January 2021

Treatment of insomnia associated with clinical depression

1 reference

7 January 2021

Residual symptoms at remission from depression: impact on long-term outcome.

1 reference

7 January 2021

Placebo-controlled trial of agomelatine in the treatment of major depressive disorder

1 reference

7 January 2021

Measuring sleep quality

1 reference

7 January 2021

Sleep disturbances and depression: a challenge for antidepressants

1 reference

7 January 2021

Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine

1 reference

7 January 2021

Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men.

1 reference

7 January 2021

Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study

1 reference

7 January 2021

Non-REM sleep instability in patients with major depressive disorder: subjective improvement and improvement of non-REM sleep instability with treatment (Agomelatine).

1 reference

7 January 2021

The medical management of depression

1 reference

7 January 2021

Antidepressants and their effect on sleep

1 reference

7 January 2021

Residual symptoms in depression: can treatment be symptom-specific?

1 reference

7 January 2021

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

1 reference

7 January 2021

Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine

1 reference

7 January 2021

The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations - a review

1 reference

7 January 2021

Residual symptoms after partial remission: an important outcome in depression

1 reference

7 January 2021

Entrainment of rat circadian rhythms by the melatonin agonist S-20098 requires intact suprachiasmatic nuclei but not the pineal

1 reference

7 January 2021

Effect of SB-243213, a selective 5-HT(2C) receptor antagonist, on the rat sleep profile: a comparison to paroxetine

1 reference

7 January 2021

1 reference

7 January 2021

Comparison between eye movement latency and REM sleep parameters in major depression.

1 reference

7 January 2021

Antidepressants and sleep: a qualitative review of the literature

1 reference

7 January 2021

Chronic exposure to melatonin receptor agonists does not alter their effects on suprachiasmatic nucleus neurons

1 reference

7 January 2021

Novel naphthalenic ligands with high affinity for the melatonin receptor

1 reference

7 January 2021

Agomelatine: a preliminary review of a new antidepressant

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.1112

1 reference

22 August 2017

1 reference